erlotinib hydrochloride has been researched along with Acute Febrile Neutrophilic Dermatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahangari, D; Colinet, B; Ngendahayo, P; Roquet-Gravy, PP | 1 |
1 other study(ies) available for erlotinib hydrochloride and Acute Febrile Neutrophilic Dermatosis
| Article | Year |
|---|---|
[A case of Sweet syndrome in a patient receiving erlotinib for lung adenocarcinoma].
Topics: Adenocarcinoma of Lung; Dermis; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neutrophil Infiltration; Protein Kinase Inhibitors; Sweet Syndrome; Time Factors | 2020 |